| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Coya Therapeutics, Inc. | Chief Executive Officer, Director | Stock Option (right to buy) | 293,983 | 22 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COYA | Coya Therapeutics, Inc. | 22 Jan 2026 | 1 | $0 | 4 | Chief Executive Officer, Director | 26 Jan 2026, 08:00 |
| COYA | Coya Therapeutics, Inc. | 09 Jan 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 13 Jan 2025, 08:00 |
| COYA | Coya Therapeutics, Inc. | 13 Nov 2024 | 1 | +$36,797 | 4 | Chief Executive Officer, Director | 13 Nov 2024, 16:05 |
| COYA | Coya Therapeutics, Inc. | 11 Nov 2024 | 1 | +$36,689 | 4 | Chief Executive Officer, Director | 12 Nov 2024, 16:58 |
| COYA | Coya Therapeutics, Inc. | 19 Aug 2024 | 0 | $0 | 3 | Director | 20 Aug 2024, 15:56 |